George Scangos Biography

Much has changed at Biogen since George Scangos a biology professor turned biotech exec became CEO in 2010. He quickly narrowed the firm’s focus to a few areas including neurological drugs like the one that became Tecfidera the blockbuster multiple-sclerosis medication introduced in 2013. With an impressive safety and efficacy record the pill’s launch has been “phenomenal” says Evercore ISI biotech analyst Mark Schoenebaum. It has also helped Biogen corner the $15 billion MS medication market and is the primary reason the firm which introduced its fifth MS drug in August is expecting 40% revenue growth in 2014. —E.F.
Contact a speaker booking agent to check availability on George Scangos and other top speakers and celebrities.

As a renowned expert and highly sought-after speaker, George Scangos's expertise is in high demand. To book George Scangos for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure George Scangos's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with George Scangos's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing George Scangos for your next speaking engagement.